Search - tctmd.com

Displaying 841 - 860 of 3073

Sort: Relevancy | Date

News Daily News

Un Estudio de Registro Vincula las PCI por OTC a una Mejor Supervivencia vs. Tratamiento Médico y CABG

September 17, 2015

Presentation

Post-ESC_15 Late-Breaking Trial Webcast: MATRIX Duration, OPTIDUAL, and PLATFORM

Presenter: Gregg W. Stone

September 15, 2015

News Daily News

El Alto Índice de Reestenosis Post-Técnica de Rescate de una OTC se asocia a un Flujo Subóptimo

September 15, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Daily News

Un Registro Traza las Tendencias en materia de Soporte Circulatorio Mecánico durante la realización de PCI

L.A. McKeown

September 14, 2015

News Daily News

OPTIMAX: Prometedores Primeros Resultados en Humanos de un Stent Biocompatible de Cobalto-Cromo

Yael L. Maxwell

September 14, 2015

News Daily News

Datos de Registro Revelan Índices Bajos de Complicaciones con el Abordaje mediante Cirugía Abierta para la TAVR Transfemoral

Todd Neale

September 14, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Industry News

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

September 10, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

COURAGE 分析：运动能力较低的患者不太可能从血运重建中获益

L.A. McKeown

September 09, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Daily News

ProGlide Supera a Prostar XL en el Cierre del Sitio de Acceso para la TAVR Transfemoral

September 09, 2015

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

News Industry News

Boston Heart Reaches Milestone in Statin Intolerance Testing

September 08, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

L.A. McKeown

September 02, 2015

News Conference News ESC 2015

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Yael L. Maxwell

September 02, 2015

Presentation ESC 2015

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Presenter: Marco Valgimigli

September 01, 2015

Advertisement

Un Estudio de Registro Vincula las PCI por OTC a una Mejor Supervivencia vs. Tratamiento Médico y CABG

Post-ESC_15 Late-Breaking Trial Webcast: MATRIX Duration, OPTIDUAL, and PLATFORM

El Alto Índice de Reestenosis Post-Técnica de Rescate de una OTC se asocia a un Flujo Subóptimo

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Un Registro Traza las Tendencias en materia de Soporte Circulatorio Mecánico durante la realización de PCI

OPTIMAX: Prometedores Primeros Resultados en Humanos de un Stent Biocompatible de Cobalto-Cromo

Datos de Registro Revelan Índices Bajos de Complicaciones con el Abordaje mediante Cirugía Abierta para la TAVR Transfemoral

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

COURAGE 分析：运动能力较低的患者不太可能从血运重建中获益

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

ProGlide Supera a Prostar XL en el Cierre del Sitio de Acceso para la TAVR Transfemoral

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

Boston Heart Reaches Milestone in Statin Intolerance Testing

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content